Fig. 3
Rates of ceftriaxone-resistant E. coli and K. pneumoniae, imipenem-resistant Gram-negative bacilli, and oxacillin-resistant S. aureus clinical isolates from 2018 to 2022
Fig. 3 | One Health Advances
Rates of ceftriaxone-resistant E. coli and K. pneumoniae, imipenem-resistant Gram-negative bacilli, and oxacillin-resistant S. aureus clinical isolates from 2018 to 2022